Yunkai K. Qie

Tianjin, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

Urinary protein semi-quantification in immunochemotherapy for bladder cancer: markers of clinical outcomes.

Urinary protein semi-quantification in immunochemotherapy for bladder cancer: markers of clinical outcomes.

Journal: Frontiers in immunology
Published: July 06, 2026

Efficacy and safety of transvaginal assisted total intracavitary orthotopic neobladder surgery for female urothelial carcinoma of the bladder

Efficacy and safety of transvaginal assisted total intracavitary orthotopic neobladder surgery for female urothelial carcinoma of the bladder

Journal: Zhonghua yi xue za zhi
Published: April 15, 2026

Cost-Effectiveness of Circulating Tumor DNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer Based on IMvigor011 Trial.

Cost-Effectiveness of Circulating Tumor DNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer Based on IMvigor011 Trial.

Journal: JCO oncology practice
Published: March 26, 2026

Magnetic resonance imaging radiomic phenotypes stratify response and define immune states in very high-risk, nonmuscle-invasive bladder cancer treated with tislelizumab plus nanoparticle albumin-bound paclitaxel.

Magnetic resonance imaging radiomic phenotypes stratify response and define immune states in very high-risk, nonmuscle-invasive bladder cancer treated with tislelizumab plus nanoparticle albumin-bound paclitaxel.

Journal: Cancer
Published: September 18, 2025

Urinary Tumor DNA to Identify Candidates for Repeat Transurethral Resection in Non-Muscle-Invasive Bladder Cancer.

Urinary Tumor DNA to Identify Candidates for Repeat Transurethral Resection in Non-Muscle-Invasive Bladder Cancer.

Journal: Cancer science
Published: September 08, 2025

E2F transcription factors as multimodal biomarkers for pan-cancer management.

E2F transcription factors as multimodal biomarkers for pan-cancer management.

Journal: Scientific reports
Published: May 24, 2025

New Constraints on Cosmic Ray-Boosted Dark Matter from the LUX-ZEPLIN Experiment.

New Constraints on Cosmic Ray-Boosted Dark Matter from the LUX-ZEPLIN Experiment.

Journal: Physical review letters
Published: March 25, 2025

Utilizing vaginal natural orifice to facilitate bowel manipulation during totally intracorporeal ileal conduit construction: a retrospective cohort study.

Utilizing vaginal natural orifice to facilitate bowel manipulation during totally intracorporeal ileal conduit construction: a retrospective cohort study.

Journal: Annals of medicine
Published: January 18, 2025

Development and validation of a nomogram for predicting prostatic urethral involvement in bladder cancer.

Development and validation of a nomogram for predicting prostatic urethral involvement in bladder cancer.

Journal: Scientific reports
Published: January 09, 2025

Impact of pelvic lymph node dissection on survival outcomes in non-muscle invasive bladder cancer: a multicenter retrospective study.

Impact of pelvic lymph node dissection on survival outcomes in non-muscle invasive bladder cancer: a multicenter retrospective study.

Journal: Scientific reports
Published: January 04, 2025

First Constraint on Atmospheric Millicharged Particles with the LUX-ZEPLIN Experiment.

First Constraint on Atmospheric Millicharged Particles with the LUX-ZEPLIN Experiment.

Journal: Physical review letters
Published: December 07, 2024

Hepatic Stellate Cell Membrane-Camouflaged Nanoparticles for Targeted Delivery of an Antifibrotic Agent to Hepatic Stellate Cells with Enhanced Antifibrosis Efficacy.

Hepatic Stellate Cell Membrane-Camouflaged Nanoparticles for Targeted Delivery of an Antifibrotic Agent to Hepatic Stellate Cells with Enhanced Antifibrosis Efficacy.

Journal: Nano letters
Published: November 25, 2024
Showing 1-12 of 35

Last Updated: 09/26/2026